BioCentury
ARTICLE | Clinical News

Amikacin Fosfomycin Inhalation System: Phase II started

January 20, 2014 8:00 AM UTC

Cardeas began the double-blind, placebo-controlled, international Phase II IASIS trial to evaluate Amikacin Fosfomycin Inhalation System delivered twice daily using the eFlow Inline Nebulizer System f...